Dexxos Participacoes SA
BOVESPA:DEXP4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dexxos Participacoes SA
BOVESPA:DEXP4
|
BR |
|
K
|
Kintor Pharmaceutical Ltd
OTC:KNTPF
|
CN |
|
ValiRx PLC
F:EAJF
|
UK |
|
H
|
Hitachi Construction Machinery Co Ltd
OTC:HTCMY
|
JP |
|
X
|
XXL ASA
LSE:0R3P
|
NO |
|
I
|
Inpex Corp
F:I8U
|
JP |
Wall St Price Targets
DEXP4 Price Targets Summary
Dexxos Participacoes SA
According to Wall Street analysts, the average 1-year price target for DEXP4 is 12.02 BRL with a low forecast of 11.9 BRL and a high forecast of 12.37 BRL.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DEXP4's stock price target?
Price Target
12.02
BRL
According to Wall Street analysts, the average 1-year price target for DEXP4 is 12.02 BRL with a low forecast of 11.9 BRL and a high forecast of 12.37 BRL.
What is the Revenue forecast for Dexxos Participacoes SA?
Projected CAGR
6%
Over the last 8 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 3 years is 6%.
What is the Operating Income forecast for Dexxos Participacoes SA?
Projected CAGR
3%
Over the last 8 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 2 years is 3%.
What is the Pre-Tax Income forecast for Dexxos Participacoes SA?
Projected CAGR
31%
Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 1 year is 31%.
What is the Net Income forecast for Dexxos Participacoes SA?
Projected CAGR
16%
Over the last 8 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 1 year is 16%.
